In another study, He et al. utilized Ec N as a carrier to transport the anticancer protein p53 and the antiangiogenic factor Tum-5 to the tumor hypoxic zone in cancer treatment, which yielded excellent tumor treatment results (He et al., 2019). Here, TP53 is linked to neoplasm.